Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113767094A reveals a robust Pd-catalyzed route for thiadiazole intermediates, offering safer manufacturing and cost reduction for pharmaceutical supply chains.
Patent CN108047009B reveals a high-yield carbonylation method using recyclable ionic liquids, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel two-step palladium-catalyzed method for polysubstituted 2-naphthols using CO and allyltin. Offers cost reduction and scalability for pharmaceutical intermediates.
Patent CN108752217B reveals a green, low-cost route for 2,4-difluorobenzylamine, a key dolutegravir intermediate, offering significant supply chain advantages.
Novel patent CN112624981B details a high-yield route for Olaparib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108003156A reveals mild double carbonylation. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN115353511A discloses a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering safer conditions and high yields for API manufacturing.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multi-component synthesis for carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN115353511A details a novel multi-component Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering cost-effective routes for API intermediates.
Patent CN112480015A reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and safety improvements for API manufacturing.
Patent CN112480015B details a Pd-catalyzed carbonylation method for quinazolinones. This breakthrough offers cost-effective, scalable routes for high-purity API intermediates.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113045503B discloses a novel Pd-catalyzed carbonylation for 2-CF3 quinazolinones. High-yield, scalable route for API intermediates like Rutaecarpine.
Patent CN115353511A introduces a novel method for synthesizing carbonyl-bridged biheterocyclic compounds without toxic CO gas, providing significant cost reduction and enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115353511A enables CO-free production of high-purity biheterocyclic intermediates with enhanced supply chain reliability and sustainable manufacturing advantages for pharma applications.
Breakthrough multi-component method eliminates toxic CO gas while achieving high substrate compatibility and scalability from lab to commercial production for reliable pharmaceutical intermediate supply.
Patent CN115353511A enables efficient synthesis without toxic CO gas, offering significant cost reduction and reliable supply for pharmaceutical intermediates manufacturing.
Patent CN115353511A introduces a novel method eliminating toxic CO gas while enabling scalable production of high-purity biheterocyclic compounds with significant cost reduction potential.
Innovative Pd-catalyzed one-pot method enables cost-effective production of high-purity quinazolinones with enhanced supply chain reliability for pharmaceutical manufacturing.